Takeda R&D is in constant pursuit of scientific breakthroughs to deliver transformative therapies to patients worldwide. This requires a vast network of experts, an unmatched understanding of our core therapeutic areas, and world-class resources. Through partnerships, collaboration, and research, we are fostering an ecosystem of innovation to translate cutting-edge science into impactful health solutions.
Through our Center for External Innovation and Partnership Office, Takeda partners with academic institutions, small biotech, and large pharmaceutical companies. We individualize each collaboration to leverage what we and our partners do best to improve patient health. Our scientific, clinical, and commercial expertise help our partners bring their visions to market.
Shonan Health Innovation Park (Shonan iPark) is Japan's first pharma-led openly innovative ecosystem built on pharmaceutical know-how where industry, government, and academia come together to promote entrepreneurship and collaboration in Japan and Globally. The Health Innovation Park is designed to:
The Innovators in Science Award, proudly sponsored by Takeda and administered by the New York Academy of Sciences, was established in November 2016. It recognizes a promising Early Career Scientist and an outstanding Senior Scientist’s contributions to science in the therapeutic areas of Neuroscience, Gastroenterology, Regenerative Medicine, and Oncology. The award is intended to support their commitment to innovative research.
Two prizes of US$200,000 are awarded each year, in a specific therapeutic area: one to an Early Career Scientist and the other to a well-established Senior Scientist from around the world who have distinguished themselves for their creative thinking and impact of research.
Learn more at www.takedainnovators.com
Takeda is a proud member of the COVID R&D Alliance focused on finding treatments through shared expertise, data, and evaluation of drug candidates.